PharmiWeb.com - Global Pharma News & Resources

Press Releases - 2024-12-12

Date Title Company
12-Dec-2024 Rancho BioSciences, LLC Awarded Great Place to Work(R) Certification for the Third Consecutive Year Newswire
12-Dec-2024 Telomir Pharmaceuticals Raises $1 Million at $7 per Share in a No-Warrant, Restricted Common Stock Deal, Representing a 20% Premium to Closing Price Newswire
12-Dec-2024 Plano Medical Waste Disposal Firm Addresses Alarming Increase in Needlestick Injuries With Comprehensive Guide AccessWire
12-Dec-2024 Elevation Oncology Licenses ADC Technology from Synaffix to Drive Pipeline Expansion Synaffix
12-Dec-2024 One year after its inclusion on WHO’s list of Neglected Tropical Diseases – what should be done next to eliminate noma? Médecins Sans Frontières (MSF)
12-Dec-2024 CellProthera Signs MOU with Shonan Kamakura General Hospital for Use of StemXpand® in Japanese Stem Cell Clinical Trial CellProthera
12-Dec-2024 Aptevo Therapeutics Announces Exercise of Warrants for $6.2 Million Gross Proceeds AccessWire
12-Dec-2024 Medios AG: Specification of the full-year forecast Medios AG
12-Dec-2024 Medical Tourism and Global Private Healthcare Drive Revenue Cycle Innovation: Black Book Report AccessWire
12-Dec-2024 Dr. Christina Campbell and Dr. Bruce Phillips launch "Hack The Code" Program for Weight Management AccessWire
12-Dec-2024 AGC Biologics to Manufacture LVV for CAR-T Therapy Approved by FDA for Autolus Therapeutics’ AUCATZYL(R) AccessWire
12-Dec-2024 AEVIS VICTORIA SA – AEVIS VICTORIA announces the acquisition of Spital Zofingen by Swiss Medical Network and a strategic partnership with Kantonsspital Aarau AEVIS VICTORIA SA
12-Dec-2024 Calls for global policy changes to address primary health services that are failing to meet men’s needs Global Action on Men’s Health (GAMH)
12-Dec-2024 Santhera Announces Approval from China’s NMPA for AGAMREE® (Vamorolone) as a Treatment for Duchenne Muscular Dystrophy Santhera Pharmaceuticals
12-Dec-2024 Allegro’s osteoarthritis injectable shock absorbing gel demonstrates preclinical safety Allegro
12-Dec-2024 ProQR Therapeutics Announces $8.1 Million in New Funding from Rett Syndrome Research Trust to Expand RNA Editing Collaboration ProQR Therapeutics
12-Dec-2024 HONEYWELL’S PHOENIX CONTROLS INTRODUCES NEW PLATFORM FOR SAFER, MORE EFFICIENT OPERATIONS IN CRITICAL ENVIRONMENTS Phoenix Controls
12-Dec-2024 electronRx to Launch purpleDx Pulmonary Disease Smartphone App for Remote Lung Function Monitoring electronRx
12-Dec-2024 Bayer starts Phase I study with SOS1 inhibitor in patients with advanced KRAS-mutated tumours Bayer
12-Dec-2024 BC Platforms-Nottingham Partnership to Power World-Leading University and Hospital Data-Sharing and Research BC Platforms